One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy
Open Access
- 26 October 2018
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 6 (12) , 493-500
Abstract
Patients with fistulizing inflammatory bowel disease are traditionally difficult to treat. This patient population often experiences delayed or insufficient healing of fistulas using current standard regimens including antibiotics, immunomodulators, anti-tumor necrosis factor-α drug, placement of setons, and surgical repair. Several studies over the last ten to fifteen years have been conducted using stem cell therapies with promising results in this patient population. These studies show stem cell therapy in fistulizing disease to be successful in healing between 60%-88% compared to currently 50% with infliximab. Moreover, remission was seen 24 wk to 52 wk in these studies. Further research with a multi-approach treatment using medications, stem cell therapy, and surgical interventions will likely be the future of this innovative treatment approach.Keywords
This publication has 17 references indexed in Scilit:
- Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s DiseaseGastroenterology, 2018
- Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseasesInflammation and Regeneration, 2017
- Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's DiseaseGastroenterology, 2017
- Stem Cell Therapy for Perianal Fistulas in Crohn's Disease.2016
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialThe Lancet, 2016
- The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategiesCancer Biology & Therapy, 2016
- Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow–Derived Mesenchymal Stem CellsMayo Clinic Proceedings, 2015
- Long-Term Results of Adipose-Derived Stem Cell Therapy for the Treatment of Crohn's FistulaStem Cells Translational Medicine, 2015
- Autologous Adipose Tissue-Derived Stem Cells for the Treatment of Crohn's Fistula: A Phase I Clinical StudyCell Transplantation, 2013
- Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trialInternational Journal of Colorectal Disease, 2012